Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs) — are the common predecessors of cells of the mesenchymal lineage, such as bone, cartilage and fat ...

It is becoming increasingly clear that cancer cells play an active part in stimulating bone-marrow-derived cells (BMDCs) to create a microenvironment that is favourable for metastasis (the ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow ... an agent known to stimulate net bone formation ...

Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications. This comes nine years after the ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow ... an agent known to stimulate net bone formation ...